Consolidated Statement of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Accumulated Deficit) [Member]	Retained Earnings (Accumulated Deficit) [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance at Mar. 30, 2019	$ 411,972		$ 1,569	$ 479,226	$ (58,208)		$ (10,615)
Beginning balance, shares at Mar. 30, 2019			56,657
Net income	58,160				58,160
Equity-based compensation	8,349			8,349
Net common stock issued under equity-based compensation plans	(2,022)		$ 1	(2,023)
Net common stock issued under equity-based compensation plans, shares			8
Foreign currency translation adjustments	(2,144)						(2,144)
Ending balance at Mar. 28, 2020	474,315	$ (245)	$ 1,570	485,552	(48)	$ (245)	(12,759)
Ending balance, shares at Mar. 28, 2020			56,665
Net income	$ 84,899				84,899
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
Equity-based compensation	$ 6,037			6,037
Net common stock issued under equity-based compensation plans	(1,630)		$ (1)	79	(1,708)
Net common stock issued under equity-based compensation plans, shares			(25)
Foreign currency translation adjustments	5,235						5,235
Ending balance at Apr. 03, 2021	568,611		$ 1,569	491,668	82,898		(7,524)
Ending balance, shares at Apr. 03, 2021			56,640
Net income	248,044				248,044
Equity-based compensation	9,777			9,777
Net common stock issued under equity-based compensation plans	(1,635)		$ 4	1,401	(3,040)
Net common stock issued under equity-based compensation plans, shares			198
Foreign currency translation adjustments	316						316
Ending balance at Apr. 02, 2022	$ 825,113		$ 1,573	$ 502,846	$ 327,902		$ (7,208)
Ending balance, shares at Apr. 02, 2022			56,838